Helmy Eltoukhy - Mar 31, 2024 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Co-Chief Executive Officer, Director
Signature
/s/ John G. Saia, as attorney-in-fact for Helmy Eltoukhy
Stock symbol
GH
Transactions as of
Mar 31, 2024
Transactions value $
-$93,021
Form type
4
Date filed
4/1/2024, 05:20 PM
Previous filing
Mar 22, 2024
Next filing
May 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Options Exercise $0 +11.5K +0.55% $0.00 2.1M Mar 31, 2024 Direct
transaction GH Common Stock Tax liability -$93K -4.51K -0.21% $20.63 2.09M Mar 31, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Restricted Stock Units Options Exercise $0 -11.5K -25% $0.00 34.4K Mar 31, 2024 Common Stock 11.5K $0.00 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2 This restricted stock unit award will vest in four equal installments on the last day of each calendar quarter, 3/31/2024, 6/30/2024, 9/30/2024, and 12/31/2024.
F3 Not applicable for Restricted Stock Units.